Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists - Concepedia

Concepedia

Publication | Open Access

Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists

DOI Full Paper Access

16

Citations

18

References

2017

Year

Martine De Vos, Barbara Dhooghe, Séverine Vermeire, Édouard Louis, Fazia Mana, Ann Elewaut, Peter Bossuyt, Filip Baert, Cathérine Reenaers, Marc Van Gossum,

United European Gastroenterology Journal

Abstract

Up to 70% TNF-refractory/intolerant UC and CD patients achieved a clinical response after 10 to 14 weeks of vedolizumab treatment in this real-life cohort.

References

	Year	Citations

Page 1